F-18 PET-CT showing large vessel vasculitis in a patient with high inflammatory markers and no localizing symptoms

Clinical Nuclear Medicine

Volumn 34, Issue 11, 2009, Pages 785-787

  Schreiber, Benjamin E ^a   Tam, Henry Ho Ching ^b   Carvalho, Chris ^c   Wong, Wai Lup ^d   Russell, Andrew I ^e   Higgens, Clare S ^e  

^a EALING HOSPITAL NHS TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c Primary Care Unit   (United Kingdom)

^d Paul Strickland Scanner Centre   (United Kingdom)

^e NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Computerized tomography; Giant cell arteritis; Positron emission tomography; Temporal arteritis

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; PREDNISOLONE; BIOLOGICAL MARKER; DIAGNOSTIC AGENT;

AGED; ANAMNESIS; ANEMIA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; TEMPORAL ARTERY; ARTERY; COMPUTER ASSISTED TOMOGRAPHY; INFLAMMATION; METABOLISM; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; VASCULITIS;

AGED; ARTERIES; BIOLOGICAL MARKERS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 73449090165     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181b7db59     Document Type: Article

References (9)

1. Chen W, Bural GG, Torigian DA, et al. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2009;36:144-151.
2. Yun M, Jang S, Cucchiara A, et al. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med. 2002;32: 70-76.
3. Walter MA. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am. 2007;45:735-744.
4. Joly L, Djaballah W, Koehl G, et al. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging. 2009;36:979-985.
5. Walter MA, Melzer RA, Schindler C, et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32:674-681.
6. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-799.
7. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246-249.
8. Scheel AK, Meller J, Vosshenrich R, et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis. 2004;63:1507-1510.
9. Brodmann M, Lipp RW, Passath A, et al. The role of 2-18F-fluoro-2-deoxy- D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology. 2004;43:241-242.